Amaryllis Nucleics is a spinoff from University of California-Davis. The company aims to democratize RNA sequencing and they are proponents of open science and open-source software. Their method for RNA-seq library synthesis takes advantage of a phenomenon called DNA breathing to capture the 5’ adapter.
Amarlyllis Nucleics is developing sequencing technology for diagnostics and epidemiology. Amaryllis Nucleics is developing a universal viral RNA detection kit that would detect COVID, Influenza, and other viral infections in the same test. The test would also detect and track mutations. The kit will use next-generation sequencing technology on a type of machine that can run thousands of samples per day.
Documentaries, videos and podcasts
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.
- IndieBioA startup accelerator for biotechnology companies located in San Francisco, California.
- SOSVSOSV (formerly SOS Ventures) is a venture capital firm founded in 1995 by Sean O'Sullivan that provides growth, seed, and venture capital funding to startups. SOSV runs six seed accelerator programs: HAX Accelerator, Chinaccelerator, MOX, IndieBio, RebelBio, and Food-X.